Skip to content
  • Tuesday, 29 September 2026
  • 12:29 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma – Pharmaceutical Technology
Pharmaceutical R&D

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma – Pharmaceutical Technology

Teuku Ryan Jun 2, 2026 0

The rapidly evolving landscape of multiple myeloma treatment is witnessing a pivotal moment with the emergence of in vivo chimeric…

Read More
Pharmaceutical R&D

The Evolving Landscape of Locally Advanced Head and Neck Squamous Cell Carcinoma Treatment Presents New Avenues for Innovation

Teuku Ryan Apr 23, 2026 0

The treatment paradigm for locally advanced head and neck squamous cell carcinoma (LA HNSCC) is undergoing a significant transformation, driven…

Read More
Artificial Intelligence Struggles with Cognitive Control as Leading Models Falter in Classic Stroop Test ExperimentsBreakthrough in Neuro-Engineering: The mAxialtrode Implant Offers New Precision for Mapping and Treating Brain DisordersRevolutionary DNA Aptamers Offer New Hope in Identifying Elusive Senescent CellsBrain Immune Cells Identified as Primary Driver of Alzheimer’s Related Sleep Loss in New Study
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
New Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease NeurodegenerationA Century of Chemistry Textbooks Got It Wrong: International Researchers Rewrite the Inductive EffectAstraZeneca Deepens Oncology Footprint with $2bn Equity Investment in Summit Therapeutics to Advance Next-Generation Cancer CombinationsThe Deep End Talk to Me podcast season explores the intersection of human identity and voice restoration technology
YOU MAY HAVE MISSED
Neuroscience & Brain Research
New Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
Rifan Muazin Sep 29, 2026
Advanced Materials Science
A Century of Chemistry Textbooks Got It Wrong: International Researchers Rewrite the Inductive Effect
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
AstraZeneca Deepens Oncology Footprint with $2bn Equity Investment in Summit Therapeutics to Advance Next-Generation Cancer Combinations
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
The Deep End Talk to Me podcast season explores the intersection of human identity and voice restoration technology
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ